MSVOX Holdings — Vitality Portfolio

All 33 reported holdings of Vitality Portfolio (MSVOX) by percentage of net assets, from the fund's latest SEC N-PORT filing.

Holding% of net assetsValue (USD)
Argenx SE8.03%$171.61K
Eli Lilly & Co7.79%$166.48K
Ascendis Pharma A/S5.48%$117.11K
Nektar Therapeutics4.75%$101.59K
Thermo Fisher Scientific Inc4.28%$91.42K
Align Technology Inc4.18%$89.32K
Enliven Therapeutics Inc3.90%$83.34K
10X Genomics Inc3.77%$80.70K
Newamsterdam Pharma Co NV3.57%$76.28K
Structure Therapeutics Inc3.36%$71.77K
Ceribell Inc3.36%$71.76K
Doximity Inc2.93%$62.63K
Intuitive Surgical Inc2.85%$60.85K
Guardant Health Inc2.73%$58.29K
Alnylam Pharmaceuticals Inc2.71%$57.90K
Vertex Pharmaceuticals Inc2.67%$57.16K
Vaxcyte Inc2.59%$55.32K
Illumina Inc2.52%$53.86K
Inspire Medical Systems Inc2.48%$53.13K
Zoetis Inc2.27%$48.58K
UnitedHealth Group Inc2.18%$46.54K
Kymera Therapeutics Inc2.08%$44.48K
Dexcom Inc1.99%$42.52K
Beam Therapeutics Inc1.79%$38.18K
West Pharmaceutical Services Inc1.71%$36.59K
AtaiBeckley Inc1.63%$34.89K
MaxCyte Inc1.63%$34.75K
Veeva Systems Inc1.56%$33.38K
Morgan Stanley & Co. LLC1.53%$32.71K
Schrodinger Inc/United States1.36%$28.99K
Tempus AI Inc1.22%$26.09K
Ultragenyx Pharmaceutical Inc0.74%$15.88K
uniQure NV0.57%$12.20K

MSVOX overview: performance, fees, allocation and SEC filings